Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
GOVX is expected to report earnings to fall 13.36% to -226 cents per share on August 12
Q2'26
Est.
$-2.27
Q1'26
Missed
by $2.08
Q4'25
Missed
by $2.27
Q3'25
Missed
by $0.02
Q2'25
Missed
by $0.05
The last earnings report on April 30 showed earnings per share of -261 cents, missing the estimate of -54 cents. With 664.84K shares outstanding, the current market capitalization sits at 7.06M.